- Home
- NAN vs XOMA Comparison
NAN vs XOMA Comparison
Compare NAN & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAN
- XOMA
- Stock Information
- Founded
- NAN 1999
- XOMA 1981
- Country
- NAN United States
- XOMA United States
- Employees
- NAN N/A
- XOMA N/A
- Industry
- NAN Investment Managers
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- NAN Finance
- XOMA Health Care
- Exchange
- NAN Nasdaq
- XOMA Nasdaq
- Market Cap
- NAN 350.0M
- XOMA 257.1M
- IPO Year
- NAN N/A
- XOMA N/A
- Fundamental
- Price
- NAN $11.55
- XOMA $20.90
- Analyst Decision
- NAN
- XOMA Strong Buy
- Analyst Count
- NAN 0
- XOMA 2
- Target Price
- NAN N/A
- XOMA $72.00
- AVG Volume (30 Days)
- NAN 74.6K
- XOMA 31.1K
- Earning Date
- NAN 01-01-0001
- XOMA 03-18-2025
- Dividend Yield
- NAN 4.37%
- XOMA N/A
- EPS Growth
- NAN N/A
- XOMA N/A
- EPS
- NAN N/A
- XOMA N/A
- Revenue
- NAN N/A
- XOMA $21,606,000.00
- Revenue This Year
- NAN N/A
- XOMA $511.37
- Revenue Next Year
- NAN N/A
- XOMA $26.92
- P/E Ratio
- NAN N/A
- XOMA N/A
- Revenue Growth
- NAN N/A
- XOMA 389.82
- 52 Week Low
- NAN $9.11
- XOMA $19.92
- 52 Week High
- NAN $11.34
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- NAN 41.01
- XOMA 27.31
- Support Level
- NAN $11.76
- XOMA $19.92
- Resistance Level
- NAN $11.89
- XOMA $22.29
- Average True Range (ATR)
- NAN 0.08
- XOMA 1.15
- MACD
- NAN -0.03
- XOMA -0.17
- Stochastic Oscillator
- NAN 10.81
- XOMA 14.20
About NAN Nuveen New York Quality Municipal Income Fund
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.